New Alzheimer Drugs on the Horizon!
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
STAY TUNED!<br />
Alzforum has <strong>the</strong> most current informati<strong>on</strong> available <strong>on</strong> <strong>the</strong> four drugs. The<br />
website's August 2015 report summarizes <strong>the</strong> outcome of this year's<br />
<str<strong>on</strong>g>Alzheimer</str<strong>on</strong>g>'s Associati<strong>on</strong> Internati<strong>on</strong>al C<strong>on</strong>ference.<br />
Aducanumab - Researchers are trying to determine <strong>the</strong> optimal dose of Adu<br />
can mab. Three dosages have underg<strong>on</strong>e trial, 3 mg, 6 mg, and 10 mg, with<br />
n<strong>on</strong>e of <strong>the</strong>m quite hitting <strong>the</strong> mark. The 10 mg dose is most effective against<br />
plaques but causes brain swelling. It was thought that a 6-mg dose would be<br />
ideal, but it has not delivered <strong>the</strong> desired outcome. Phase 3 of <strong>the</strong> study will<br />
c<strong>on</strong>tinue exploring drug dosages versus side effects.